“Does the dose of hydroxyurea correlate with shorter hospital stay and higher fetal hemoglobin levels in patients with sickle cell disease?”

Background & Aims Sickle cell disease (SCD) leads to recurrent vaso-occlusive crises (VOC) and hospitalizations, imposing a substantial healthcare burden. Hydroxyurea (HU) is known to reduce VOC frequency and hospitalization rates in SCD; however, data comparing the impact of different HU doses on l...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Musa Fares Alzahrani, Abdulaziz Albacker, Abdulmajeed Alshabanat, Maram Alharbi, Jawahir Abuhaimed, Nouran Arnous, Yara Alzahrani, Hind Aloraier, Maha Alamri, Rawan Altamimi, Ghazi Alotaibi, Sarah Sewaralthahab, Fatima Alshalti, Ibrahim Alrumaih, Ahmad Jamal, Farjah Algahtani, Aamer Aleem
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2026-12-01
coleção:	Future Science OA
Assuntos:	Sickle cell disease sickle SCD hydroxyurea vaso-occlusive crisis
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/20565623.2025.2610223
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!